May 15, 2019, 06:30 pm

Pharma company with office in Wilmington gets orphan status for cancer drug

 15-05-2019 6:30 PM

Ayala Pharmaceuticals, a clinical-stage company, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration for AL101. Ayala has offices in Wilmington and Israel. Orphan Drug Designation is granted to drug therapies intended to treat diseases...

Posted in: Tags:
Delaware Business Now
Delaware Business Now

This article was posted online by Delaware Business Now. Spot On Delaware collects excepts of news articles from this news source and add these in the 'Delaware Business'-category. For mor einformation about Spot On Delaware, you can check the About Us-page.

This story was posted in the category: